Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Date : 13 February 2026
| Company | Description |
| Thermo Fisher Scientific Inc. | This majorly offers tools to assist in the design, delivery, and validation of miRNA sponges. |
| QIAGEN N.V. | Its portfolio emphasizes the functional analysis, quantification, and detection of microRNAs. |
| GenScript Biotech Corporation | This company mainly facilitates comprehensive molecular biology and custom RNA synthesis services. |
| System Biosciences (SBI) | It has unveiled custom anti-miRNA services using their miRZip technology. |
| AcceGen Biotech | A firm provides high-quality service for the construction of miRNA sponge vector clones. |
| GeneCopoeia, Inc. | Its offering includes a set of microRNA (miRNA) inhibition solutions. |
| Abcam plc (Danaher) | This explores tools and infrastructure to encourage microRNA research through other solutions. |
| Merck KGaA (Sigma-Aldrich) | A company usually provides a complete suite of tools for microRNA (miRNA) research, like solutions for miRNA silencing and inhibition. |
| Horizon Discovery (Revvity) | This offers inhibiting or silencing miRNA function through the Dharmacon brand. |
| Takara Bio Inc. | It facilitates many related products and services for miRNA research, such as tools for extraction, quantification, and expression. |
The global microRNA sponge service market size was estimated at USD 150.12 million in 2025 and is predicted to increase from USD 183.06 million in 2026 to approximately USD 1091.19 million by 2035, expanding at a CAGR of 21.94% from 2026 to 2035.
Ready to see the full mRNA MicroRNA Sponge Service Market picture under one place? - Explore the Dashboard Now
Speak with a healthcare analyst about your research, consulting, or platform needs.